Influenza A Virus, H3N2 Subtype
-
Subject Areas on Research
-
A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infection.
-
A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2.
-
A host-based RT-PCR gene expression signature to identify acute respiratory viral infection.
-
A shortened interval between vaccinations with the trivalent inactivated influenza vaccine increases responsiveness in the aged.
-
An individualized predictor of health and disease using paired reference and target samples.
-
Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection.
-
Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.
-
Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification.
-
Detection of viruses via statistical gene expression analysis.
-
Development and preclinical evaluation of an alphavirus replicon vaccine for influenza.
-
Differential evolution of peripheral cytokine levels in symptomatic and asymptomatic responses to experimental influenza virus challenge.
-
Differential pulmonary transcriptomic profiles in murine lungs infected with low and highly virulent influenza H3N2 viruses reveal dysregulation of TREM1 signaling, cytokines, and chemokines.
-
Gene Expression Profiles Link Respiratory Viral Infection, Platelet Response to Aspirin, and Acute Myocardial Infarction.
-
H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination.
-
High Risk of Influenza Virus Infection Among Swine Workers: Examining a Dynamic Cohort in China.
-
Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
-
Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine.
-
Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope.
-
Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
-
Iridoids and sesquiterpenoids from Valeriana jatamansi and their anti-influenza virus activities.
-
Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections.
-
Nasopharyngeal Protein Biomarkers of Acute Respiratory Virus Infection.
-
Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection.
-
Pattern recognition molecule mindin promotes intranasal clearance of influenza viruses.
-
Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013.
-
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season.
-
Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.
-
Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection.
-
The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA.
-
The impact of host immune status on the within-host and population dynamics of antigenic immune escape.
-
Unsupervised Bayesian linear unmixing of gene expression microarrays.
-
Keywords of People